Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients.

Oxidants, oxidative stress and the biology of ageing. Nature (2000) 23.21

Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature (1997) 13.77

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail (2012) 10.38

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med (2008) 9.19

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Suppression of aging in mice by the hormone Klotho. Science (2005) 8.11

FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22

Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke (2009) 6.62

Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol (2010) 4.59

Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett (2004) 4.02

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation (2012) 3.07

Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem (2005) 2.94

Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res (2005) 2.63

Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun (2001) 2.63

Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol (2012) 2.22

Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int (2009) 2.10

In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun (2000) 1.97

Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. Kidney Int (2012) 1.92

KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Hum Genet (2003) 1.90

Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol (2013) 1.78

Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol (2013) 1.78

Circulating α-klotho levels in CKD and relationship to progression. Am J Kidney Dis (2013) 1.76

Klotho protein protects against endothelial dysfunction. Biochem Biophys Res Commun (1998) 1.74

Effects of cinacalcet treatment on serum soluble Klotho levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant (2011) 1.55

Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. J Mol Med (Berl) (2004) 1.50

Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exp Nephrol (2012) 1.28

Plasma klotho and mortality risk in older community-dwelling adults. J Gerontol A Biol Sci Med Sci (2011) 1.25

The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol (2014) 1.21

Plasma klotho and cardiovascular disease in adults. J Am Geriatr Soc (2011) 1.20

Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol (2014) 1.16

A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One (2013) 1.15

Secreted klotho and chronic kidney disease. Adv Exp Med Biol (2012) 1.13

Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease. BMC Nephrol (2012) 1.08

Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4. Clin J Am Soc Nephrol (2014) 1.06

Klotho variants and chronic hemodialysis mortality. J Bone Miner Res (2009) 1.02

Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate. J Am Soc Nephrol (2014) 0.96

Determination of Kt/V and protein catabolic rate using pre- and postdialysis blood urea nitrogen concentrations. Nephron (1994) 0.95

Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients. Nephrol Dial Transplant (2011) 0.94

Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism. J Clin Endocrinol Metab (2014) 0.94

Serum soluble α-klotho in hemodialysis patients. Clin Nephrol (2012) 0.92

The impact of nephrectomy and renal transplantation on serum levels of soluble Klotho protein. Transplant Proc (2013) 0.91

The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients. Clin Exp Nephrol (2012) 0.91

Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients. BMC Nephrol (2014) 0.89

Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study. BMJ Open (2014) 0.89

Febuxostat for hyperuricemia in patients with advanced chronic kidney disease. Drug Target Insights (2014) 0.89

Soluble α -Klotho Serum Levels in Chronic Kidney Disease. Int J Endocrinol (2015) 0.89

Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression. Kidney Int (2013) 0.88

Renal Production, Uptake, and Handling of Circulating αKlotho. J Am Soc Nephrol (2015) 0.86

Prognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients. PLoS One (2014) 0.82

Measurement of serum soluble Klotho levels in CKD 5D patients: useful tool or dispensable biomarker? Nephrol Dial Transplant (2012) 0.81

The association of Klotho gene polymorphism with the mortality of patients on maintenance dialysis. Clin Nephrol (2013) 0.80

Negative outcome studies in end-stage renal disease. Blood Purif (2008) 0.80

Effect of continuous positive airway pressure on proteinuria in obstructive sleep apnea. Clin Kidney J (2012) 0.77

Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease. PLoS One (2017) 0.75